A British biotechnology firm that supplies big pharmaceutical firms with synthetic antibodies for targeted delivery of drugs will float in London this week valued at £80.7m – giving its two founders a combined paper fortune of more than £33m.
Aptamer Group was founded in 2008 by Dr Arron Tolley, 34, an early school leaver who later completed a doctorate in biophysics and molecular biology, and Dr David Bunka, a geneticist. Today, the York-based company has partnerships with the vast majority of the world’s top 20 pharmaceutical firms, including Britain’s biggest drugmaker, AstraZeneca, and Japan’s Takeda.
When the two founders first met at Leeds University, Tolley was doing a PhD in virology, studying DNA packaging mechanisms in viruses. “We
Read more on theguardian.com